Compare Stocks: SKHHY, DGX, LH, and GH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$241.80 +0.0%	$217.76	$171.18 ▼ $245.68	$26.69B	0.56	956,121 shs	1.14 million shs
GH Guardant Health	$167.88 +2.8%	$152.39	$53.40 ▼ $176.58	$22.53B	1.6	2.31 million shs	2.55 million shs
LH Labcorp	$332.67 +0.7%	$289.75	$244.52 ▼ $338.19	$26.98B	0.87	680,442 shs	731,833 shs
SKHHY Sonic Healthcare	$15.18 -11.3%	$14.92	$12.94 ▼ $17.49	$7.50B	0.64	107,941 shs	15,056 shs

10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	+2.14%	+1.79%	+16.55%	+24.84%	+32.28%
GH Guardant Health	+2.01%	-1.07%	+10.31%	+38.41%	+178.88%
LH Labcorp	+2.51%	+2.44%	+17.77%	+29.36%	+19.78%
SKHHY Sonic Healthcare	+5.00%	+8.23%	+12.87%	+27.99%	-9.81%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$241.80 +0.0%	$217.76	$171.18 ▼ $245.68	$26.69B	0.56	956,121 shs	1.14 million shs
GH Guardant Health	$167.88 +2.8%	$152.39	$53.40 ▼ $176.58	$22.53B	1.6	2.31 million shs	2.55 million shs
LH Labcorp	$332.67 +0.7%	$289.75	$244.52 ▼ $338.19	$26.98B	0.87	680,442 shs	731,833 shs
SKHHY Sonic Healthcare	$15.18 -11.3%	$14.92	$12.94 ▼ $17.49	$7.50B	0.64	107,941 shs	15,056 shs

10 Best Stocks to Own - Summer 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	+2.14%	+1.79%	+16.55%	+24.84%	+32.28%
GH Guardant Health	+2.01%	-1.07%	+10.31%	+38.41%	+178.88%
LH Labcorp	+2.51%	+2.44%	+17.77%	+29.36%	+19.78%
SKHHY Sonic Healthcare	+5.00%	+8.23%	+12.87%	+27.99%	-9.81%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DGX Quest Diagnostics	2.54	Moderate Buy	$235.31	-2.68% Downside
GH Guardant Health	2.96	Moderate Buy	$183.78	9.47% Upside
LH Labcorp	2.75	Moderate Buy	$330.00	-0.80% Downside
SKHHY Sonic Healthcare	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest SKHHY, DGX, LH, and GH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/12/2026	DGX Quest Diagnostics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Buy (B+) ➝ Buy (A-)
8/10/2026	LH Labcorp	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$355.00
8/4/2026	GH Guardant Health	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$170.00 ➝ $195.00
8/4/2026	GH Guardant Health	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$135.00 ➝ $193.00
8/4/2026	GH Guardant Health	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$175.00 ➝ $185.00
8/4/2026	LH Labcorp	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$300.00 ➝ $309.00
8/3/2026	LH Labcorp	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$330.00 ➝ $360.00
7/31/2026	LH Labcorp	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$308.00 ➝ $338.00
7/31/2026	GH Guardant Health	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$185.00 ➝ $200.00
7/31/2026	GH Guardant Health	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$210.00
7/31/2026	LH Labcorp	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$306.00

(Data available from 8/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DGX Quest Diagnostics	$11.04B	2.42	$15.53 per share	15.57	$70.84 per share	3.41
GH Guardant Health	$982.02M	22.94	N/A	N/A	($1.66) per share	-101.13
LH Labcorp	$14.35B	1.88	$25.63 per share	12.98	$106.13 per share	3.13
SKHHY Sonic Healthcare	$6.25B	1.20	$0.63 per share	24.07	$11.10 per share	1.37

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DGX Quest Diagnostics	$992M	$9.42	25.67	20.20	2.18	9.18%	16.01%	7.27%	10/20/2026 (Estimated)
GH Guardant Health	-$416.28M	-$3.49	N/A	N/A	N/A	-38.33%	N/A	-25.40%	10/28/2026 (Estimated)
LH Labcorp	$876.50M	$12.09	27.52	16.92	1.86	6.99%	16.74%	7.81%	10/27/2026 (Estimated)
SKHHY Sonic Healthcare	$332.61M	N/A	N/A	16.87	N/A	N/A	N/A	N/A	8/20/2026 (Estimated)

Latest SKHHY, DGX, LH, and GH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/20/2026	N/A	SKHHY Sonic Healthcare	$0.4619	N/A	N/A	N/A	$3.80 billion	N/A
7/30/2026	Q2 2026	GH Guardant Health	-$0.7618	-$0.42	+$0.3418	-$0.90	$314.23 million	$334.98 million
7/30/2026	Q2 2026	LH Labcorp	$4.78	$4.99	+$0.21	$3.64	$3.71 billion	$3.73 billion
7/23/2026	Q2 2026	DGX Quest Diagnostics	$2.82	$3.12	+$0.30	$2.84	$2.97 billion	$3.04 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DGX Quest Diagnostics	$3.44	1.42%	+7.34%	36.52%	14 Years
GH Guardant Health	N/A	N/A	N/A	N/A	N/A
LH Labcorp	$2.88	0.87%	N/A	23.82%	N/A
SKHHY Sonic Healthcare	$0.56	3.69%	N/A	N/A	N/A

Latest SKHHY, DGX, LH, and GH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/12/2026	DGX Quest Diagnostics	quarterly	$0.86	1.45%	10/6/2026	10/6/2026	10/21/2026
7/9/2026	LH Labcorp	quarterly	$0.72	1.04%	8/28/2026	8/28/2026	9/11/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DGX Quest Diagnostics	0.72	1.59	1.46
GH Guardant Health	N/A	4.03	3.71
LH Labcorp	0.69	1.80	1.53
SKHHY Sonic Healthcare	0.59	1.01	0.90

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DGX Quest Diagnostics	88.06%
GH Guardant Health	92.60%
LH Labcorp	95.94%
SKHHY Sonic Healthcare	0.01%

Insider Ownership

Company	Insider Ownership
DGX Quest Diagnostics	0.88%
GH Guardant Health	5.60%
LH Labcorp	0.84%
SKHHY Sonic Healthcare	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DGX Quest Diagnostics	57,000	110.37 million	109.40 million	Optionable
GH Guardant Health	2,506	134.20 million	126.68 million	Not Optionable
LH Labcorp	71,000	81.10 million	80.42 million	Optionable
SKHHY Sonic Healthcare	45,000	494.24 million	N/A	Not Optionable

SKHHY, DGX, LH, and GH Headlines

Recent News About These Companies

Sonic Healthcare (SKHHY) Projected to Announce Quarterly Earnings on Thursday

August 13, 2026 | americanbankingnews.com

SONIC HEALTHCARE SP/ADR by Sonic Healthcare Ltd. Insider Trading Activity | OTC:SKHHY | Benzinga

June 24, 2026 | benzinga.com

Sonic Healthcare Limited (SKHHY) Q2 2026 Earnings Call Transcript

February 18, 2026 | seekingalpha.com

Sonic Healthcare Limited (SKHHY) Shareholder/Analyst Call Transcript

November 24, 2025 | seekingalpha.com

Sonic Healthcare holds AGM after posting strong FY25 growth and reaffirming FY26 outlook

November 19, 2025 | msn.com

All You Need to Know About Sonic Healthcare Ltd. Sponsored ADR (SKHHY) Rating Upgrade to Buy

August 28, 2025 | zacks.com

SKHHY | Sonic Healthcare Ltd. ADR Financial Statements - WSJ

August 8, 2025 | wsj.com

Sonic Healthcare (ASX:SHL) May Have Issues Allocating Its Capital

July 30, 2025 | finance.yahoo.com

Sonic Healthcare Limited Announces Cessation of Securities

June 16, 2025 | tipranks.com

Sonic Healthcare initiated with a Buy at Goldman Sachs

April 4, 2025 | markets.businessinsider.com

Sonic Healthcare initiated with an Equal Weight at Morgan Stanley

March 20, 2025 | finance.yahoo.com

Sonic Healthcare Ltd ADR

March 12, 2025 | morningstar.comM

A Look At The Fair Value Of Sonic Healthcare Limited (ASX:SHL)

March 11, 2025 | finance.yahoo.com

Jarden Sticks to Their Hold Rating for Sonic Healthcare Limited (SHL)

February 26, 2025 | markets.businessinsider.com

UBS Reaffirms Their Hold Rating on Sonic Healthcare Limited (SHL)

February 23, 2025 | markets.businessinsider.com

Elliott Wave Technical Analysis - Sonic Healthcare Limited

February 11, 2025 | talkmarkets.com

Sonic Healthcare Limited (SHL) Gets a Hold from Jefferies

February 9, 2025 | markets.businessinsider.com

Elliott Wave Technical Analysis: Sonic Healthcare Limited

February 4, 2025 | talkmarkets.com

RBC Capital Sticks to Their Hold Rating for Sonic Healthcare Limited (SHL)

December 11, 2024 | markets.businessinsider.com

Sonic Healthcare agrees to acquire LADR for $446.9m

December 9, 2024 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SKHHY, DGX, LH, and GH Company Descriptions

Quest Diagnostics NYSE:DGX

$241.80 +0.04 (+0.02%)

Closing price 03:58 PM Eastern

Extended Trading

$238.39 -3.41 (-1.41%)

As of 05:49 PM Eastern

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Guardant Health NASDAQ:GH

$167.88 +4.54 (+2.78%)

Closing price 04:00 PM Eastern

Extended Trading

$169.50 +1.62 (+0.97%)

As of 06:07 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Labcorp NYSE:LH

$332.67 +2.23 (+0.67%)

Closing price 03:58 PM Eastern

Extended Trading

$337.46 +4.78 (+1.44%)

As of 06:15 PM Eastern

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Sonic Healthcare OTCMKTS:SKHHY

$15.18 -1.94 (-11.33%)

As of 03:59 PM Eastern

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SKHHY, DGX, LH, and GH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SKHHY, DGX, LH, and GH Earnings

Compare Dividends

Latest SKHHY, DGX, LH, and GH Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SKHHY, DGX, LH, and GH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SKHHY, DGX, LH, and GH Company Descriptions

Quest Diagnostics NYSE:DGX

Guardant Health NASDAQ:GH

Labcorp NYSE:LH

Sonic Healthcare OTCMKTS:SKHHY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools